Introduction {#s1}
============

Prominent eosinophilic infiltration of the liver is commonly seen in visceral larva migrans histologically presenting palisading granuloma \[[@R01], [@R02]\]. Occasional eosinophilic infiltration to some degree is known in drug-induced hypersensitivity as well as primary sclerosing cholangitis (PSC) \[[@R03]\], primary biliary cirrhosis (PBC) \[[@R04]\]. Hypereosinophilic syndrome (HES) is indispensable disease related to eosinophilic hepatic necrosis, although it is rare.

Hypereosinophilic syndrome is thought to be a heterogeneous group of disorders characterized by peripheral eosinophilia and involvement of various organs. The diagnosis needs exclusion of other specific causes for eosinophilia such as infectious disease (parasitosis), autoimmune diseases (Churg-Strauss syndrome, Wegener granulomatosis), allergic inflammation to specific antigen, and neoplastic hematopoietic disorders \[[@R05]\]. Hepatic involvement of hypereosinophilic syndrome is uncommon, however, has been suggested to associate with the various type of liver injury. For example, cholangitis \[[@R06]\], chronic active hepatitis (CAH) \[[@R07]\], Budd-Chiari syndrome \[[@R08]\], and nodular regenerative hyperplasia (NRH) \[[@R9]\] has been reported in the patients of hypereosinophilic syndrome.

Herein, we present the case of hypereosinophilia with hepatic eosinophilic necrosis in liver histology and multiple liver mass lesions on radiological findings, which was difficult to differentiate from malignancy.

Case Report {#s2}
===========

A 70-year-old Japanese male complained fever and back pain. He was pointed out liver injury on blood examination. Imaging studies revealed multiple space-occupying lesion (SOL) of the liver. He was admitted for the examination of liver SOL. He has no familial history, no medication, no any allergy, animal pet, and habits of eating raw meat. In past history, he suffered cholecystlithiasis several years ago. Laboratory data at admission is shown in [Table 1](#T1){ref-type="table"}. The counts of white blood cell (WBC) elevated, particularly eosinophil increased markedly up to 62% (13200/µl). IgE RIST was high level and eosinophil cationic protein (ECP) was mildly elevated, which implied allergic or other inflammatory reaction with involvement of the eosiophil in the process \[[@R10]\]. The serologic test for *Toxocara* species was negative. Transaminase and biliary enzyme were moderately increased. Noticeable elevation of tumor markers was nothing, except for soluble interluekin-2 receptor (sIL-2R).

###### Laboratory Data at Admission (Normal Range)

  Item              Value                                     Item       Value
  ----------------- ----------------------------------------- ---------- -----------------------------
  RBC               452 × 10^4^ /µl (390 - 520 × 10^4^ /µl)   LDH        654 IU/l (110 - 220 IU/l)
  WBC               213 × 10^2^ /µl (33 - 90 × 10^2^ /µl)     CRP        2.7 mg/dl (\< 0.3 mg/dl)
  Eosinophil        62% (1-5%)                                IgE RIST   1457.2 IU/ml (\< 400 IU/ml)
  Platelet          17.3 × 10^4^ /µl (15 - 35 × 10^4^ /µl)    ECP        33.0 µg/l (\< 14.7 µg/l)
  AST               110 IU/l (12 - 36 IU/l)                   IL-4       (-) (\< 15 pg/ml)
  ALT               108 IU/l (3 - 32 IU/l)                    IL-5       (-) (\< 8 pg/ml)
  ALP               499 IU/l (114 - 394 IU/l)                 IL-6       (-) (\< 8 pg/ml)
  γ-GTP             64 IU/l (9 - 71 IU/l)                     sIL-2R     4483 U/ml (190 - 650 U/ml)
  Total bilirubin   0.57 mg/dl (0.1 - 1.0 mg/dl)              DUPAN-2    273 U/ml (\< 150 U/ml)
  Total protein     6.1 g/dl (6.5 - 8.0 g/dl)                 PIVKA-II   14 mAU/ml (\< 40 mAU/ml)
  Amylase           116 IU/l (58 - 166 IU/l)                  CA19-9     (-) (\< 37 U/ml)
  Creatinine        0.75 mg/dl (0.6 - 1.2 mg/dl)              HBsAg      (-)
  BUN               13.7 mg/dl (10 - 20 mg/dl)                HCV-Ab     (-)

ALT, alanine aminotransferase; ALP, alkaline phosphatase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; CA19-9, Carbohydrate antigen 19-9; CRP, C-reactive protein; ECP, Eosinophil cationic protein; γ-GTP, gamma-glutamyl transpeptidase; HBsAg; hepatitis B surface antibody, HCV-Ab; hepatitis C virus antibody, IgE, immunoglobulin E; IL-4, interleukin-4; IL-5, interleukin-5; IL-6, interleukin-6; LDH, lactate dehydrogenase; PIVKA-II, protein induced by vitamin K absence or antagonist-II; Plt, platelet; RBC, red blood cell; sIL-2R, soluble interleukin-2 receptor; WBC, white blood cell.

Radiological finding showed multiple mass lesions of the liver ([Fig. 1](#F1){ref-type="fig"}). Those lesions were low density on abdominal CT, which were not enhanced. MRI image showed low-intensity on T1-weight and iso-intensity on T2-weight. Metastatic tumor, cholangiocarcinoma, malignant lymphoma, and inflammatory pseudotumor were candidates as differential diagnosis. Bilateral pleural effusion was pointed out in extrahepatic organ.

![Radiological findings of the liver. (a) Enhanced CT of delayed phase. Multiple low density areas are detected in the whole liver. The lesions show nodular or geographic, and no enhanced effects. (b, c) MRI images. These lesions are iso or low intensity in T1-weight image (b), and iso or hyper intensity in T2-weight image (c).](gr-04-168-g001){#F1}

After admission, he complained asthma-like symptom and pleural fluid was detected by chest CT. The liver biopsy was performed for diagnosis of the mass lesions. Liver needle biopsy revealed multifocal eosinophile's infiltrative lesion in portal tracts and hepatic parenchyma ([Fig. 2a, b](#F2){ref-type="fig"}). Cellular atypia of eosinophile was not distinct. The majority of infiltrative cells were eosinophil in parenchyma, whereas lymphocytes were mixed to some degree in portal tracts. The lymphocytes showed small round nuclei without atypia, and polyclonal on immunohistological findings. The granulomatous reaction was not observed at all. The fragments of necrotic tissue were seen here and there, and a lot of Charcot-Leyden's crystals were found in the necrotic area ([Fig. 2c, d](#F2){ref-type="fig"}).

![Histological findings of the liver needle biopsy. (a) The foci of eosinophil's aggregates and hepatocyte's dropouts are seen in liver parenchyma (surrounded by head of arrow). (HE, original magnification, x100). (b) The border of the eosinophile's aggregates are relatively clear and cellular atypia of eosinophile are not apparent. (HE, original magnification, x400). (c) Asterisk areas are composed necrotic cells (HE, original magnification, x100). (d) (d) is high magnification of the asterisk area of (c). Charcot-Leyden crystals are scattered in necrotic area, which show lightly eosinophilic and bipyramidal or hexagonal in shape on sections. (HE, original magnification, x1000).](gr-04-168-g002){#F2}

The steroid pulse therapy was undergone after liver biopsy. The count of eosinophile in peripheral blood fell down rapidly within normal range after steroid therapy. The hepatic masses became gradually reduced and disappeared in about half a year. He has been followed for 5 years and no recurrence.

Discussion {#s3}
==========

Eosinophilia is generally categorized into clonal, secondary, and idiopathic types. Clonal eosinophilia is diagnosed by the presence of histologic, cytogenetic, or molecular evidence of an underlining myeloid malignancy. Actually, a lot of examination including the assessment of peripheral blood smear, bone marrow morphologic features, cytogenetic analysis, mutation analysis of specific gene, lymphocyte phenotyping, and T-cell receptor gene rearrangement are needed to rule out the clonal eosinophilia \[[@R11]\]. Our case is unlikely clonal type because of rapid improvement against steroid therapy, before vigorous examination.

Secondary eosinophilia is caused by parasite infection, allergic, systemic vasculitis, drugs, and nonmyeloid malignancy. In our case, parasite infection, particularly visceral larva migrans, had to be differentiated because hepatic involvement with eosinophilia and multiple lesion on imaging is frequently observed. To our knowledge, the characteristic histological finding of parasitic infection is eosinophilic granuloma in almost cases, except one case of hydatid disease showing eosinophilic cholangitis \[[@R01], [@R02], [@R12]-[@R13]\]. It seemed that the possibility of visceral larva migrans could be denied because the granulomatous reaction was not found at all in liver biopsy, and antihelminthic treatment was not needed in our patient. Specific factor determining cause of eosinophilia didn't detected over five years, although it seems to be difficult complete exclusion of secondary eosinophilia.

HES is a subcategory of idiopathic type, and defined by the presence of a peripheral blood eosinophil count of 1.5 × 10^9^/L or greater for at least 6 months, exclusion of both clonal and secondary eosinophilia, evidence of organ involvement, like as Chusid et al. proposed in 1975 \[[@R11], [@R14]\]. This case didn't fill strictly above criteria, however, he was good responder of corticosteroid therapy, which is the first-line therapy for HES \[[@R05]\]. A shorter duration by the proper therapy has been allowed for diagnosis for HES \[[@R11]\], therefore, this case likely to be HES.

Liver involvement of the HES does occur in the frequency of 43% \[[@R15]\]. We review the cases reported as HES, which hepatic histology has been evaluated by liver biopsy in [Table 2](#T2){ref-type="table"}. The variety of histological findings seems reflect the heterogeneity of HES. The hepatic histology of HES is classified into four types: 1) cholangitis type; 2) chronic active hepatitis (CAH) type; 3) vasculopathic type; 4) hepatic necrosis type. Prominent eosinophilic infiltration to portal tracts, bile ducts, venous system, or hepatic parenchyma were observed in each type. The characteristics and differential diagnosis are raised in each group. 1), Cholangitis type (case No. 1 - 5). All patients were man and icteric. The discrimination form PSC were discussed quite often, because similarity of radiological or histological findings, and also complication of eosinophilic colitis, which is consistent with inflammatory bowel disease. 2), CAH type (case No. 6 - 9). Non-specific radiological finding, portal fibrosis with interface eosinophilic hepatitis in histology, and practicable disease control by steroid therapy are characteristics in this groups. PBC, as well as autoimmune hepatitis (AIH) should be excluded by careful clinical follow up and repeated histological examination, because actually AMA-positive, or ANA-positive patient was reported \[[@R20], [@R21]\]. 3), Vasculopathic type (case No. 10, 11). Case 11 with Budd-Chiari syndrome and FIP1L1-PDGFRA fusion gene is currently categorized into myeloid and lymphoid neoplasm with eosinophilia and abnormalities of platelet derived growth factor receptor α (PDGFRA), PDGFRB or fiibroblast growth factor receptor (FGFR1) in the revised 2008 WHO classification system, and definitely excluded from HES \[[@R23]\]. No abnormalities were detected in chromosomal analysis including Philadelphia chomosome in NRH patients (case No. 10) at the point, but the patients had persisted liver injury over two years despite of steroid, and also hydroxyurea, and thioguanine \[[@R9]\]. Vigorous examination of specific fusion gene and chromosomal abnormalities might be needed whenever encounter the vasculopathic type considering the possibility of neoplastic disease. 4), Hepatic necrosis type (case No. 12, 13). The notable characteristics of this group is hepatic multiple mass lesion pointed out on radiologists, which are difficult to distinguish from malignancy, such as cholangiocellular carcinoma, metastatic carcinoma, or malignant lymphoma \[[@R24]-[@R26]\]. Needle biopsy seems essential to exclude above malignancy and also visceral larva migrans, which leads to avoid inappropriate surgery or medication. The patients, just two in reports, both immediately improved against steroid therapy in clinical and radiological findings, which seems to suggest that the group has unlikely neoplastic nature. Drug intake should always remind whenever eosinophilic infiltration is seen in liver, if any pattern.

###### Reviewer of the Cases Reported as HES

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Case   Age   Sex   Clinical finding                          Radiological finding                                                                              Pathological finding                                                   Effective therapy                      Associated abnormality                             Reference
  ------ ----- ----- ----------------------------------------- ------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------- -------------------------------------- -------------------------------------------------- -------------------------------
  1      28    M     Abdominal cramps, diarrhea, jaundice      Diffuse narrowing and strictures of biliary system (PSC-compatible)                               Cholangitis with eosinpophilic infiltration (PSC-like)                 Steroid hydroxyurea                    Colitis with eosinophilic infiltration             Scheurlen et al \[[@R16]\]

  2      41    M     Abdominal pain, fever, jaundice           Stricture and dilatation in extrahepatic bile duct (PSC-compatible)                               Eosinophilic sclerosing cholangitis                                    Steroid                                                                                   Grauer et al \[[@R06]\]

  3      58    M     Jaundice, fatigue, abdominal pain         Normal                                                                                            Eosinophilic cholangitis                                               Steroid                                                                                   Dillon et al \[[@R17]\]

  4      20    M     Jaundice, fever                           Hepatomegaly, diffuse irregular appearance (PSC-like)                                             Eosinophilic cholangitis                                               Steroid, aminosalicylic acid (5-ASA)   Colitis with eosinophilic infiltration (UC-like)   Schoonbroodt et al \[[@R18]\]

  5      52    M     Diarrhea, jaundice                        NS                                                                                                Eosinophilic cholangitis                                               NS                                     Colitis with eosinophilic infiltration             Sussman et al \[[@R19]\]

  6      20    M     Fatigue, myalgia, night sweat             NS                                                                                                Chronic active hepatitis with eosinophilic infiltration                Steroid                                AMA (NS)\                                          Croffy et al \[[@R20]\]
                                                                                                                                                                                                                                                                               ANA (+)                                            

  7      34    M     Nausea, jaundice                          NS                                                                                                Chronic active hepatitis with eosinophilic infiltration                Steroid                                AMA (NS)\                                          Croffy et al \[[@R20]\]
                                                                                                                                                                                                                                                                               ANA (-)                                            

  8      19    M     Jaundice, pruritic rash                   Hepatomegaly                                                                                      Chronic active hepatitis with eosinophilic infiltration                Steroid                                AMA (-)\                                           Foong et al \[[@R07]\]
                                                                                                                                                                                                                                                                               ANA (-)                                            

  9      65    F     Arthralgias                               Normal                                                                                            Chronic hepatitis with confluent eosinophilic centrilobular necrosis   Steroid                                AMA (+), ANA (-)                                   Ung et al \[[@R21]\]

  10     52    M     Malaise, nausea, dizziness, weight loss   Hepatomegaly                                                                                      NRH, portal eosinophilic infiltration                                  Steroid, hydroxyurea, thiaguanine      Esophageal varix                                   Bennie et al \[[@R9]\]

  11     27    M     Abdominal fullness                        Obstruction of the hepatic veins and stricture of the inferior vena cava (Budd-Chiari syndrome)   Obstructive thrombophlebitis with eiosinophilic infiltration           Interventinal therapy, steroid         Fusion of the FIP1L1 and PDGFRA gene (+)           Inoue et al \[[@R08]\]

  12     52    F     Abdominal pain                            Liver masses                                                                                      Hepatic eosinophilic infiltration                                      Steroid                                                                                   Lai et al \[[@R22]\]

  13     70    M     Back pain, fever                          Liver masses                                                                                      Hepatic eosinophilic infiltration                                      Steroid                                                                                   Our case
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

AMA, anti-mitochondrial antibody; ANA, anti-nuclear antibody; F, female; FIP1L1, FIP1-like 1 gene; M, male; NRH, nodular regenerative hyperplasia; NS, not stated; PDGFRA, platelet derived growth factor receptor α; PSC, primary sclerosing cholangitis; UC, ulcerative colitis.

We presented in this article the case of hepatic eosinophilic necrosis showed liver mass lesions and reviewed the liver histology of HES. In conclusion, the histology is categorized four types: cholangitis type, CAH type, vasculopathic type, and hepatic necrosis type. PSC, PBC, AIH, neoplastic eosinophilia, parasitic infection, malignancy, and drug can be differential disease in each type. It is important that HES is one of the mass forming disease in liver, and liver biopsy is useful to exclude differential disease for steroid therapy.
